VEGFA and neoplasm: Previously, we reported that treatment of nude mice implanted s.c. with LM8 cells into the backs with troglitazone, a peroxisome proliferator-activated receptor-γ (PPARγ) ligand, decreased the expression of MMP-2 and VEGF within the primary tumor and inhibited the development of pulmonary metastasis [8].